Pyruvate kinase M2 regulates mitochondrial homeostasis in cisplatin-induced acute kidney injury

Abstract An important pathophysiological process of acute kidney injury (AKI) is mitochondrial fragmentation in renal tubular epithelial cells, which leads to cell death. Pyruvate kinase M2 (PKM2) is an active protein with various biological functions that participates in regulating glycolysis and p...

Full description

Bibliographic Details
Main Authors: Wenjia Xie, Qingyun He, Yan Zhang, Xinxin Xu, Ping Wen, Hongdi Cao, Yang Zhou, Jing Luo, Junwei Yang, Lei Jiang
Format: Article
Language:English
Published: Nature Publishing Group 2023-10-01
Series:Cell Death and Disease
Online Access:https://doi.org/10.1038/s41419-023-06195-z
_version_ 1797659789190234112
author Wenjia Xie
Qingyun He
Yan Zhang
Xinxin Xu
Ping Wen
Hongdi Cao
Yang Zhou
Jing Luo
Junwei Yang
Lei Jiang
author_facet Wenjia Xie
Qingyun He
Yan Zhang
Xinxin Xu
Ping Wen
Hongdi Cao
Yang Zhou
Jing Luo
Junwei Yang
Lei Jiang
author_sort Wenjia Xie
collection DOAJ
description Abstract An important pathophysiological process of acute kidney injury (AKI) is mitochondrial fragmentation in renal tubular epithelial cells, which leads to cell death. Pyruvate kinase M2 (PKM2) is an active protein with various biological functions that participates in regulating glycolysis and plays a key role in regulating cell survival. However, the role and mechanism of PKM2 in regulating cell survival during AKI remain unclear. Here, we found that the phosphorylation of PKM2 contributed to the formation of the PKM2 dimer and translocation of PKM2 into the mitochondria after treatment with staurosporine or cisplatin. Mitochondrial PKM2 binds myosin heavy chain 9 (MYH9) to promote dynamin-related protein 1 (DRP1)-mediated mitochondrial fragmentation. Both in vivo and in vitro, PKM2-specific loss or regulation PKM2 activity partially limits mitochondrial fragmentation, alleviating renal tubular injury and cell death, including apoptosis, necroptosis, and ferroptosis. Moreover, staurosporine or cisplatin-induced mitochondrial fragmentation and cell death were reversed in cultured cells by inhibiting MYH9 activity. Taken together, our results indicate that the regulation of PKM2 abundance and activity to inhibit mitochondrial translocation may maintain mitochondrial integrity and provide a new therapeutic strategy for treating AKI.
first_indexed 2024-03-11T18:21:19Z
format Article
id doaj.art-9c23e06ccd1844ceb74d54130b36a983
institution Directory Open Access Journal
issn 2041-4889
language English
last_indexed 2024-03-11T18:21:19Z
publishDate 2023-10-01
publisher Nature Publishing Group
record_format Article
series Cell Death and Disease
spelling doaj.art-9c23e06ccd1844ceb74d54130b36a9832023-10-15T11:30:12ZengNature Publishing GroupCell Death and Disease2041-48892023-10-01141011110.1038/s41419-023-06195-zPyruvate kinase M2 regulates mitochondrial homeostasis in cisplatin-induced acute kidney injuryWenjia Xie0Qingyun He1Yan Zhang2Xinxin Xu3Ping Wen4Hongdi Cao5Yang Zhou6Jing Luo7Junwei Yang8Lei Jiang9Center for Kidney Disease, The Second Affiliated Hospital, Nanjing Medical UniversityCenter for Kidney Disease, The Second Affiliated Hospital, Nanjing Medical UniversityCenter for Kidney Disease, The Second Affiliated Hospital, Nanjing Medical UniversityCenter for Kidney Disease, The Second Affiliated Hospital, Nanjing Medical UniversityCenter for Kidney Disease, The Second Affiliated Hospital, Nanjing Medical UniversityCenter for Kidney Disease, The Second Affiliated Hospital, Nanjing Medical UniversityCenter for Kidney Disease, The Second Affiliated Hospital, Nanjing Medical UniversityCenter for Kidney Disease, The Second Affiliated Hospital, Nanjing Medical UniversityCenter for Kidney Disease, The Second Affiliated Hospital, Nanjing Medical UniversityCenter for Kidney Disease, The Second Affiliated Hospital, Nanjing Medical UniversityAbstract An important pathophysiological process of acute kidney injury (AKI) is mitochondrial fragmentation in renal tubular epithelial cells, which leads to cell death. Pyruvate kinase M2 (PKM2) is an active protein with various biological functions that participates in regulating glycolysis and plays a key role in regulating cell survival. However, the role and mechanism of PKM2 in regulating cell survival during AKI remain unclear. Here, we found that the phosphorylation of PKM2 contributed to the formation of the PKM2 dimer and translocation of PKM2 into the mitochondria after treatment with staurosporine or cisplatin. Mitochondrial PKM2 binds myosin heavy chain 9 (MYH9) to promote dynamin-related protein 1 (DRP1)-mediated mitochondrial fragmentation. Both in vivo and in vitro, PKM2-specific loss or regulation PKM2 activity partially limits mitochondrial fragmentation, alleviating renal tubular injury and cell death, including apoptosis, necroptosis, and ferroptosis. Moreover, staurosporine or cisplatin-induced mitochondrial fragmentation and cell death were reversed in cultured cells by inhibiting MYH9 activity. Taken together, our results indicate that the regulation of PKM2 abundance and activity to inhibit mitochondrial translocation may maintain mitochondrial integrity and provide a new therapeutic strategy for treating AKI.https://doi.org/10.1038/s41419-023-06195-z
spellingShingle Wenjia Xie
Qingyun He
Yan Zhang
Xinxin Xu
Ping Wen
Hongdi Cao
Yang Zhou
Jing Luo
Junwei Yang
Lei Jiang
Pyruvate kinase M2 regulates mitochondrial homeostasis in cisplatin-induced acute kidney injury
Cell Death and Disease
title Pyruvate kinase M2 regulates mitochondrial homeostasis in cisplatin-induced acute kidney injury
title_full Pyruvate kinase M2 regulates mitochondrial homeostasis in cisplatin-induced acute kidney injury
title_fullStr Pyruvate kinase M2 regulates mitochondrial homeostasis in cisplatin-induced acute kidney injury
title_full_unstemmed Pyruvate kinase M2 regulates mitochondrial homeostasis in cisplatin-induced acute kidney injury
title_short Pyruvate kinase M2 regulates mitochondrial homeostasis in cisplatin-induced acute kidney injury
title_sort pyruvate kinase m2 regulates mitochondrial homeostasis in cisplatin induced acute kidney injury
url https://doi.org/10.1038/s41419-023-06195-z
work_keys_str_mv AT wenjiaxie pyruvatekinasem2regulatesmitochondrialhomeostasisincisplatininducedacutekidneyinjury
AT qingyunhe pyruvatekinasem2regulatesmitochondrialhomeostasisincisplatininducedacutekidneyinjury
AT yanzhang pyruvatekinasem2regulatesmitochondrialhomeostasisincisplatininducedacutekidneyinjury
AT xinxinxu pyruvatekinasem2regulatesmitochondrialhomeostasisincisplatininducedacutekidneyinjury
AT pingwen pyruvatekinasem2regulatesmitochondrialhomeostasisincisplatininducedacutekidneyinjury
AT hongdicao pyruvatekinasem2regulatesmitochondrialhomeostasisincisplatininducedacutekidneyinjury
AT yangzhou pyruvatekinasem2regulatesmitochondrialhomeostasisincisplatininducedacutekidneyinjury
AT jingluo pyruvatekinasem2regulatesmitochondrialhomeostasisincisplatininducedacutekidneyinjury
AT junweiyang pyruvatekinasem2regulatesmitochondrialhomeostasisincisplatininducedacutekidneyinjury
AT leijiang pyruvatekinasem2regulatesmitochondrialhomeostasisincisplatininducedacutekidneyinjury